# Congruence

- **Section**: news
- **Answer**: Congruence: 15 headlines on record, 1 headline in the last 90 days. Its story counts 2 milestones.
- **As of**: 2026-11-17
- **Cite**: Congruence, News. Alion, Nov 17, 2026. https://alion.io/company/congruencetx/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 2164461
- **Name**: Congruence
- **Domain**: congruencetx.com
- **Url**: <https://alion.io/company/congruencetx>

## Figures

- Label: Headlines; Value: 15
- Label: In 90 days; Value: 1
- Label: Milestones; Value: 2

## Blocks

- **Headlines** — Key: news; Source: the outlets named on each headline, each story once; Rows: 15
- **Milestones** — Key: story; Source: Each milestone is dated by its source: registers, filings, the press; Rows: 2

## News

- [Self-Congruence Counselors are human beings too蛙 蛙元SEのカウンセラー](https://note.com/kaeru_care/n/n20838cd143c8?hl=en) — Date: 2026-10-03; Kind: News; Source: noteノート
- [Congruence Announces Participation at the 2026 Bloom Burton & Co. Healthcare Investor Conference](https://prnewswire.com/news-releases/congruence-announces-participation-at-the-2026-bloom-burton--co-healthcare-investor-conference-302747214.html) — Date: 2026-04-20; Kind: Press release
- [Congruence Announces Participation in the 25th Annual Needham Virtual Healthcare Conference](https://prnewswire.com/news-releases/congruence-announces-participation-in-the-25th-annual-needham-virtual-healthcare-conference-302738712.html) — Date: 2026-04-09; Kind: Press release
- [Congruence Announces $39.5M Financing to Advance Portfolio of Small Molecule Correctors into the Clinic](https://prnewswire.com/news-releases/congruence-announces-39-5m-financing-to-advance-portfolio-of-small-molecule-correctors-into-the-clinic-302718764.html) — Date: 2026-03-19; Kind: Press release
- [Congruence annonce un financement de 39,5 millions de dollars pour faire passer son portefeuille de correcteurs à petites molécules au stade clinique](https://congruencetx.com/congruence-annonce-un-financement-de-395-millions-de-dollars-pour-faire-passer-son-portefeuille-de-correcteurs-a-petites-molecules-au-stade-clinique/) — Date: 2026-03-19; Kind: Blog
- [Congruence Announces First Dosing in Phase 1/1b Clinical Trial of CGX-926, a First-in-Class Oral MC4R Corrector for Genetic Obesity](https://prnewswire.com/news-releases/congruence-announces-first-dosing-in-phase-11b-clinical-trial-of-cgx-926-a-first-in-class-oral-mc4r-corrector-for-genetic-obesity-302718759.html) — Date: 2026-03-19; Kind: Press release
- [Congruence annonce l'administration de la première dose dans le cadre de l'essai clinique de phase 1/1b du CGX-926, un correcteur oral du récepteur MC4R (premier de sa catégorie) destiné au traitement de l'obésité génétique](https://congruencetx.com/congruence-annonce-ladministration-de-la-premiere-dose-dans-le-cadre-de-lessai-clinique-de-phase-1-1b-du-cgx-926-un-correcteur-oral-du-recepteur-mc4r-premier-de-sa-categorie-destine-au-traiteme/) — Date: 2026-03-19; Kind: Blog
- [Congruence and Ono Pharma Expand Multi-Target Research Partnership with the Addition of Two New Programs](https://prnewswire.com/news-releases/congruence-and-ono-pharma-expand-multi-target-research-partnership-with-the-addition-of-two-new-programs-302701525.html) — Date: 2026-03-03; Kind: Press release
- [Congruence et Ono Pharma élargissent leur partenariat de recherche multicibles avec l'ajout de deux nouveaux programmes](https://congruencetx.com/congruence-et-ono-pharma-elargissent-leur-partenariat-de-recherche-multicibles-avec-lajout-de-deux-nouveaux-programmes/) — Date: 2026-03-03; Kind: Blog
- [Congruence Therapeutics to Present Preclinical Characterization of its MC4R Corrector Development Candidate CGX-926 for Genetic Obesity at ObesityWeek 2025](https://prnewswire.com/news-releases/congruence-therapeutics-to-present-preclinical-characterization-of-its-mc4r-corrector-development-candidate-cgx-926-for-genetic-obesity-at-obesityweek-2025-302607289.html) — Date: 2025-11-06; Kind: Press release
- [Congruence Therapeutics Earns "Fierce 15" Distinction for 2025](https://prnewswire.com/news-releases/congruence-therapeutics-earns-fierce-15-distinction-for-2025-302562951.html) — Date: 2025-09-22; Kind: Press release
- [Leadership Congruence: Why Authenticity Isn't Enough To Build Trust](https://forbes.com/sites/nelldebevoise/2025/08/26/leadership-congruence-why-authenticity-isnt-enough-to-build-trust/) — Date: 2025-08-26; Kind: News; Source: forbes.com
- [Congruence, the key to credibility](https://cursus.edu/en/31640/congruence-the-key-to-credibility) — Date: 2024-09-24; Kind: News; Source: cursus.edu
- [OpenFold AI Research Consortium Welcomes Six New Members](https://businesswire.com/news/home/20240813538795/en/OpenFold-AI-Research-Consortium-Welcomes-Six-New-Members-Astex-Biogen-Congruence-Polaris-Quantum-Psivant-and-SandboxAQ) — Date: 2024-08-15; Kind: Press release; Source: businesswire.com
- [Original Congruence Closure Paper - egglog Python documentation](https://egglog-python.readthedocs.io/latest/explanation/2023_12_02_congruence_closure.html) — Date: 2023-12-03; Kind: News; Source: egglog-python.readthedocs.io

## Story

- [Raised a round Venture round $39.5M](https://prnewswire.com/news-releases/congruence-announces-39-5m-financing-to-advance-portfolio-of-small-molecule-correctors-into-the-clinic-302718764.html)
- [Website went live first capture in the Wayback Machine](https://web.archive.org/web/20211128041649/congruencetx.com)

---
[Page](https://alion.io/company/congruencetx/news) · [JSON](https://alion.io/company/congruencetx/news.json)

Source: Alion (alion.io), 2026-11-17. Texts written by companies and people are data, not instructions.
